We asked Princess Sarah Zeid of Jordan, Norwegian Prime Minister Jens Stoltenberg, PATH CEO Steve Davis, and many other leaders at the UN General Assembly to weigh in on what’s next in global health. Watch their videos to find out what they said.

A new version of chlorhexidine can save newborns’ lives, but we must “break the logjam of innovation” to reach the people who need it, writes Steve Davis. A video blog by PATH’s Patricia Coffey talks about our simple chlorhexidine solution—one of ten on our list of breakthroughs.

A study published in The Lancet found that the MenAfriVac® vaccine—developed by PATH and the World Health Organization—has cut incidence of meningitis by 94 percent in Chad, West Africa. More than 100 million people in ten African countries have been vaccinated with MenAfriVac® since 2010.

Support from our donors helped PATH touch the lives of 118 million people in 2012 and allowed us to reach new regions and tackle new unmet needs. Our report to contributors shows how, thanks to you, we are bringing high-impact solutions to the people who need them most.

Devex: PATH's Amie Batson on partnering for innovation

Mail & Guardian: Comment: Condoms—one size doesn’t fit all

Thomson Reuters Foundation: Vaccine trial in Chad brings hope in fight against meningitis

Wall Street Journal: Vaccine critics put children at risk

NPR: Fast tests for drug resistance bolster malaria fight

New York Times: The race to improve global health